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Objectives. This study determined the frequency ofimprovement 
in peak oxygen uptake and its role in reevaluation f candidates 
awaiting heart ransplantation. 
Background. Ambulatory candidates for transplantation usu- 
ally wait >6 months to undergo the procedure, and during this 
period symptoms may lessen, and peak oxygen uptake may 
improve. Whereas initial transplant candidacy is based increas- 
ingly on objective criteria, there are no established guidelines for 
reevaluation todetermine who can leave the active waiting list. 
Methods. All ambulatory transplant candidates with initial 
peak oxygen uptake < 14 ml/kg per min were identified. Of 107 
such patients listed, 68 survived without early deterioration or
transplantation to undergo repeat exercise. A strategy of reeval- 
uation using specific linical criteria and exercise performance 
was tested to determine whether patients with improved oxygen 
uptake could safely be followed without ransplantation. 
Results. In 38 of the 68 patients, peak oxygen uptake increased 
by >2 ml/kg per rain to a level >12 ml/kg per min after 6 +- 
5 months, together with an increase in anaerobic threshold, peak 
oxygen pulse and exercise heart rate reserve and a decrease in 
heart rate at rest. Increased peak oxygen uptake was accompanied 
by stable clinical status without congestion i  31 of 38 patients, 
and these 31 were taken off the active waiting list. At 2 years, their 
actuarial survival rate was 100%, and the survival rate without 
relisting for transplantation was 85%. 
Conclusion. Reevaluation of exercise capacity and clinical 
status allowed removal of 31 (29%) of 107 ambulatory transplant 
candidates from the waiting list with excellent early survival 
despite low peak oxygen uptake on initial testing. The ability to 
increase peak oxygen uptake, particularly with increased peak 
oxygen pulse, may indicate improved prognosis as well as func- 
tional capacity and, in combination with stable clinical status, 
may be an indication to defer transplantation in favor of more 
compromised candidates. 
(J Am Colt Cardiol 1995;25:163-70) 
Although the success of heart transplantation has stimulated 
increasing referrals of patients with heart failure, the number 
of donor hearts has not increased significantly during the past 
3 years (1), and the average waiting time to transplantation for
outpatient candidates in the United States currently exceeds 
500 days (Timothy Breen, personal communication, United 
Network of Organ Sharing). During this time, outpatients are 
at risk of clinical deterioration requiring hospitalization for 
hemodynamic support until transplantation and at risk of 
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sudden death, for which the monthly risk is highest during the 
1st 6 months that they are on the active transplant candidate 
list (2). Those candidates who survive at home frequently 
demonstrate progressive improvement after redesign of their 
medical therapy (3,4). 
The limited supply of donors and the restricted life span of the 
donor heart justify the strategy of postponing transplantation i  
patients who improve to become comfortable and functional, as 
long as their expected mortality rate does not significantly exceed 
that expected with transplantation. The traditional indications of 
listing for transplantation patients who have "end-stage" or 
"refractory" heart failure have recently been supplemented by 
more objective criteria including exercise peak oxygen uptake 
<14 ml/kg per min, shown by Mancini et al. (5) to identify those 
patients at highest risk without transplantation. However, peak 
oxygen uptake has been shown to improve with vasodilator and 
exercise therapy in patients with less severe heart failure (6-8). 
When can an outpatient candidate who was initially listed for 
appropriate indications be considered for removal from the active 
candidate list? 
~C, 1995 by the American College of Cardiology 0735-1097/95/$9.50 
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This study addressed the hypotheses that 1) improvement i  
oxygen uptake could frequently be demonstrated in patients 
with initial oxygen consumption <14 ml/kg per min, and 2) 
serial measurement of peak oxygen uptake may be incorpo- 
rated into a strategy to identify transplant candidates who can 
safely be removed from the active waiting list despite initial 
peak oxygen uptake <14 ml/kg per rain. 
Methods 
Study patients. Consecutive ambulatory patients under- 
going formal evaluation for heart transplantation from 1988 
through 1992 were chosen for this study if 1) they demon- 
strated apeak oxygen uptake <14 ml/kg per rain after achiev- 
ing a respiratory quotient >1, and 2) they did not have major 
medical or psychosocial contraindications to heart transplan- 
tation (9). Patients were excluded from this study if they had 
diseases other than dilated heart failure, such as hypertrophic 
and primary restrictive cardiomyopathy, for which natural 
history and some other considerations may vary. 
Exercise testing. Patients underwent a warm-up eriod for 
6 rain on the bicycle at a constant work load of 20 W. They 
were then allowed to rest for 5 to 15 min, until heart rate 
returned to baseline. Further rest was allowed if necessary 
until oxygen consumption returned to the initial baseline value. 
Incremental work load bicycling was then begun, with 2 to 
3 rain of unloaded cycling followed by continuously increasing 
work load at 15 W/min. The respiratory exchange ratio was 
monitored and all patients were encouraged toexercise past a 
ratio = 1 to limiting symptoms. Breath by breath gas analysis 
was performed with the Medical Graphics 2000 metabolic cart. 
Oxygen uptake (Vo2), carbon dioxide release (Vcoz), ventila- 
tion, ventilatory equivalents for oxygen and carbon dioxide 
were measured continuously, using averages of 8 breaths. 
Blood pressure and heart rate were measured at 3-rain inter- 
vals and at peak exercise. Anaerobic threshold was estimated 
by the V-slope method and confirmed by ventilatory criteria. 
All ambulatory patients without unstable angina or refrac- 
tory ventricular arrhythmias underwent exercise testing at 
baseline. All candidates surviving without ransplantation u - 
derwent repeat esting between 3 and 12 months after initial 
evaluation unless they had developed greater instability with 
respect o angina or hemodynamic decompensation. I  the 
later years of the study, repeat esting was performed within 6 
months of the initial test (48 of 68 retested patients). 
Medical management. After initial screening on referral, 
all patients advancing to formal evaluation underwent right 
heart catheterization to determine pulmonary pressures, resis- 
tance and gradient as part of the determination f transplant 
eligibility. Patients with pulmonary capillary wedge pressure 
>20 mm Hg or cardiac index <2.2 liters/min per m 2 had the 
catheter left in place for adjustment ofvasodilator and diuretic 
therapy (4). Vasodilators and diuretic agents were tailored to 
approach emodynamic goals of pulmonary capillary wedge 
pressure -<15 mm Hg and systemic vascular esistance -<1,200 
dynes-s.cm -5 while maintaining systolic blood pressure at 
Table 1. Reassessment of Waiting Candidates 
Clinical criteria for stability 
1. Stable fluid balance without orthopnea, elevated jugular venous 
pressures or other evidence of congestion on the flexible diuretic regimen 
2. Stable blood pressure with systolic pressure ->80 mm Hg 
3. Stable serum sodium levels and renal function 
4. Absence of symptomatic ventricular arrhythmias 
5. Absence of frequent angina 
6. Absence of severe drug side effects 
7. Stable or improving activity level without dyspnea during self-care or 
exertion for 1 block 
Exercise criteria (if initial peak Vo2 < 14 ml/kg per rain) 
1. Improvement in peak 4o2 by >-2 ml/kg per rain 
2. Peak ~'o 2 >-12 ml/kg per min 
~/O 2 = oxygen uptake. 
->80 mm Hg as described for transplant candidates (4). During 
the 1st 2 years of the study period, hemodynamic optimization 
was designed with either captopril or hydralazine in combina- 
tion with oral nitrate therapy; after the results of the Hy-C trial 
in October 1990 (10), all patients without contraindications to 
angiotensin-converting e zyme inhibitors were initially given a 
captopril-isosorbide dinitrate combination, with the addition 
or substitution ofhydralazine orincreased isosorbide dinitrate, 
or both, if necessary to achieve adequate vasodilation without 
unacceptable side effects. The diuretic regimen was based on 
loop diuretics and adjusted according to daily weight, with the 
intermittent addition of metolazone if necessary. Amiodarone 
was the preferred antiarrhythmic agent if therapy was thought 
to be indicated for atrial or ventricular rrhythmias. From June 
1989 onward, amiodarone was recommended not only for 
symptomatic arrhythmias, but as part of a prospective trial in 
patients with heart failure who had high grade ventricular 
arrhythmias detected on ambulatory monitoring. 
Patients did not undergo formal rehabilitation or training 
but were instructed to walk without stopping at least 4 times 
weekly, outdoors or in covered shopping malls, starting at a 
time and distance comfortably achieved and increasing weekly 
to a target duration of 20 to 30 min or 2 miles. Patients were 
taught o check their heart rate and advised to achieve a level 
close to that observed at the onset of anaerobic metabolism as 
estimated from their baseline xercise test. 
Candidacy for transplantation. I  the absence of formally 
approved guidelines for transplant selection during the study 
period, evaluated patients with peak oxygen uptake < 14 ml/kg 
per min who were without major medical or psychosocial 
contraindications (9) were generally listed for heart ransplan- 
tation. If awaiting further support system evaluation or com- 
pliance clearance (for smoking cessation, for example), pa- 
tients for this study were considered to have been listed after 
initial evaluation. Patients in the last year of the study (18 
patients) were informed at the time of listing that candidacy 
was a dynamic state that could change if their functional 
capacity improved or if noncardiac problems developed. 
All listed transplant candidates were seen at intervals of 2 to 
4 weeks by the center cardiologists, who evaluated them for 
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Table 2. Baseline Characteristics at Initial Evaluation of68 Heart Transplant Candidates With and 
Without Later Major Improvement 
With Improvement 
Without Major Remaining Removed 
Improvement on List From List 
(n - 30) (n - 7) (n = 31) 
Age (yr) 54 ± 8 53 ± 14 53 ± 10 
Male gender 26 4 25 
Coronary artery disease 14 4 13 
Alcohol history 2 1 3 
Ejection fraction 0.22 ± 0.08 0.19 _+ 0.04 0.24 + 0.07 
Cardiac index (liters/min per m 2) 2.0 ± 0.5 1.8 ± 0.4 2.2 _+ 0.9 
Pulmonary wedge pressure (mm Hg) 27 2 10 29 ± 8 24 - 11 
Right atrial pressure (ram Hg) 14 ± 7 13 +_ 5 12 _+ 6 
Initial peak "~o 2 (ml/kg per rain) 10 + 2 10 + 3 11 _+ 2 
No significant differences were observed between groups. Data are presented as number of patients or mean value 
± SD. List = waiting list for heart transplantation; "vo 2 - oxygen uptake. 
clinical stability (Table 1), as described previously (3). The 
strategy of reevaluation required that both the criterion of 
adequate exercise improvement and the preceding criteria for 
clinical stability had to be met before a patient could be 
removed from the active candidate list. Adequate exercise 
improvement was defined as an increase in peak oxygen uptake 
of >-2 ml/kg per min to a level >-12 ml/kg per min. All potential 
candidates continued to be followed up in the cardiomyopathy 
center whether or not they remained on the active list. Listing 
for transplantation, transplantation a d death without rans- 
plantation were all analyzed as end points. 
Statistical analysis. The three patient groups (1) without 
improvement, 2) with improvement and remaining on the 
transplant list, and 3) with improvement but removed from the 
list) were compared by using PROC GLM (SAS V.6.04). 
General comparisons were performed with analysis of vari- 
ance, pairwise comparisons with Tukey's test. We also used 
contrasts to compare patients removed from the list versus 
others and patients with versus those without improvement. 
Changes within groups were assessed by paired t tests. Values 
were expressed as mean value +_ SD; p < 0.05 was considered 
significant. Actuarial survival was determined by Kaplan-Meier 
life-table analysis. 
Resu l t s  
Serial exercise performance. There were 107 ambulatory 
patients considered to be transplant candidates with peak 
oxygen uptake <14 ml/kg per rain (average 10 ml/kg per min). 
Of these, 39 did not undergo repeat esting because of either 
severe angina (n = 12), marked hemodynamic deterioration 
(n = 6), intervening transplantation (n = 15) or death (n = 6). 
The remaining 68 patients underwent repeat esting 6 +_ 5 
months after initial evaluation. 
Major improvement i  exercise performance, defined as an 
increase in peak oxygen uptake >-2 ml/kg per min to a level 
>-12 ml/kg per rain, occurred in 38 of the 68 patients. Demo- 
graphic and hemodynamic profiles at baseline and frequency of 
coronary artery disease were not significantly different between 
the groups with and without improvement (Table 2). However, 
the baseline xercise performance of the patients with subse- 
quent improvement was characterized by higher peak heart 
rate, exercise heart rate reserve, work load, and initial anaer- 
obic threshold (Table 3). 
Therapy at discharge from initial evaluation was similar for 
patients with and without improvement (Table 4). The major- 
ity were able to tolerate angiotensin-converting e zyme inhib- 
itors without severe hypotension (systolic blood pressure 
<80 mm Hg) or worsening renal function. Amiodarone was 
added in a similar proportion of patients in both groups. 
Improvement in peak oxygen consumption was accompa- 
nied by an improvement i  anaerobic threshold and work load. 
Patients whose improvement allowed their removal from the 
transplant list demonstrated increased exercise heart rate 
reserve, increased peak systolic blood pressure (without 
change in blood pressure at rest) and increased oxygen pulse 
(Table 5). In these patients the increased heart rate reserve at 
reevaluation reflected a lower rest heart rate than that at initial 
evaluation (71 vs. 83 beats/min, p < 0.05). 
Clinical reevaluation of listed outpatient candidates. Of 
the 38 patients with exercise improvement, 31 met the criteria 
for clinical stability. Among the other seven patients, four had 
continued recurrent episodes of fluid retention requiring in- 
travenous diuretic drug therapy (although not on the day of 
the repeat exercise), two had improved exercise capacity to 
<13 ml/kg per rain and continued to be severely limited in 
routine activities and one patient had frequent angina. 
The seven patients with improved exercise performance but 
without sutficient clinical stability to allow removal from the 
transplant list formed too small a group for meaningful 
comparisons. During their initial exercise test, peak heart rate, 
heart rate reserve and peak work load were similar to those 
patients whose exercise capacity did not subsequently improve 
(Table 3). The increased peak oxygen consumption i these 
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Table 3. Initial Exercise Performance of 68 Heart Transplant Candidates With and Without Later 
Major Improvement 
With 
Major Improvement 
Without Remaining Removed 
Major Improvement on List From List 
(n -30)  (n 7) (n -31)  
Peak exercise Wo 2 (ml/kg per min) 10 4- 2 10 + 3 11 ± 2 
0 2 pulse (ml/beat) 6.2 4- 3.0 5.2 ± 3.0 6.9 4- 2.5 
Baseline heart rate (beats/min) 82 4- 20 83 -+ 34 83 4- 19 
Peak heart rate (beats/min) 117 4- 34* 115 _+ 50 138 4- 24 
Exercise heart rate reserve (beats/min) 32 ± 23* 32 4- 20 55 -+ 20-~ 
Watts 55 4- 28* 57 4- 38 79 4- 25t 
Peak VcoflVo 2 (R) 1.11 4- 0.25 1.16 4- 0.06 1.20 _+ 0.17 
AT (ml/kg per min) 6.6 4- 2.8* 7.9 4- 2.3 9.1 4- 2.1t 
Peak VE (liters/rain) 46 _+ 23 50 4- 11 47 4- 14 
Peak VENo2 59 ± 19 66 ± 17 58 _+ 22 
Peak VENco 2 53 _+ 17 58 + 16 50 4- 17 
*p < 0.05 between patients with and without improvement. ~p < 0.05 between patients with improvement removed 
from the list and all others. All data are presented as mean value + SD. AT = anaerobic threshold; R - respiratory 
quotient; Vco 2 = carbon dioxide release; VE = ventilation; other abbreviations as in Table 2. 
seven patients without clinical stability resulted from an in- 
creased peak exercise heart rate without a major increase in 
oxygen pulse (Table 5). 
The 31 patients manifesting clinical stability were advised, 
as were their families, that their condition had improved such 
that transplantation was not expected to yield major improve- 
ment in exercise capacity or survival during the following year. 
They were informed that their condition might deteriorate or 
that other complications precluding transplantation might 
develop. The risk of sudden death during the next year was 
Table 4. Therapy at Discharge for the 68 Heart Transplant Candidates After Initial Evaluation 
for Transplantation 
With Major Improvement 
Without Major Remaining Removed 
Improvement on List From List 
~n - 30) (n = 7) (n - 31) 
Previous therapy with angiotensin-converting enzyme inhibitors 
No. of patients 19 4 19 
Discharge therapy 
Captopril 
No. of patients 17 4 18 
Dose (mg/day) 204 _+ 131 255 4- 110 206 4- 148 
Enalapril 
No. of patients 2 0 4 
Dose (mg/day) 30 4- 0 19 _+ 13 
Hydralazine 
No. of patients 5 2 9 
Dose (mg/day) 540 _+ 80 466 4- 125 422 + 92 
Isosorbide dinitrate 
No. of patients 19 7 20 
Dose (mg/day) 101 ± 75 129 4- 57 140 4- 80 
Furosemide therapy 
No. of patients 30 7 31 
Dose (mg/day) 
At referral 101 4- 84 98 + 83 75 ± 78 
At discharge 108 4- 69 123 + 122 90 4- 56 
Amiodarone therapy 
No. of patients 
Previous therapy 2 0 2 
At discharge 10 2 13 
Data are presented as number of patients or mean value + SD. 
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Table 5. Changes inExercise Performance of the 68 Heart Transplant Candidates 
With Major 
Improvement 
Without Major Remained Removed 
Improvement on List From List 
(n = 30) (n = 7) (n = 31) 
Increase in peak "QO 2 (ml/kg per rain) 0.7 -+ 3 4 _+ 3* 5 -+ 3* 
Increase in AT (ml/kg per min) 0.05 -+ 1.77 2.3 _+ 1.5" 2.7 _+ 2.0":~ 
Increase in peak watts 6 _+ 22t 30 _+ 15" 28 _+ 28* 
Change in peak R -0.04 _+ 0.10 0.02 + 0.04 -0.03 _+ 0.17 
Change in rest HR (beats/min) -1 + 13 -3  -+ 11 -11 _+ 20* 
Increase in peak HR (beats/rain) 2 _+ 21 13 +_ 18 -1 _+ 25 
Increase in exercise HR reserve (beats/min) 3 _+ 21 16 _+ 16" 10 -+ 25* 
Increase in O z pulse (mlfoeat) 0.3 +- LOt 0.7 +_ 1.2 2.5 +_ 2.4':~ 
Change in rest SBP (mm Hg) -1  --- 17 -2  -2-- 11 -3  + 17 
Change in peak SBP (mm Hg) 4 _+ 25 -5 -+ 6 15 _+ 25'$ 
*Significant change from baseline. ?Significant difference between patients without improvement and patients with 
major improvement. :~Significant difference between patients with improvement who were removed from the list and all 
others. All data are presented as mean value +_ SD. HR = heart rate; SBP = systolic blood pressure; other abbreviations 
as in Table 3. 
described to them as 15% to 25% (based on multicenter 
experience [11] and the earlier experience of this institution 
[12], although the recent incidence has been lower [10]). They 
were told that this risk was slightly but not substantially higher 
than the risks of fatal rejection, infection and other complica- 
tions during the 1st year after transplantation. Subsequent 
reevaluation was planned to take place at 3-month intervals or 
in the event of clinical deterioration; if the latter had occurred 
they would rejoin the active waiting list with the previously 
accrued waiting time. These 31 patients, who had a mixed 
emotional response to this information, were then taken off the 
active transplant candidate list. 
Survival and transplantation. Of the 30 patients without 
major improvement in exercise capacity, 5 are currently alive 
awaiting transplantation (Fig. 1). The seven patients who had 
improved exercise capacity but remained on the active trans- 
plant candidate list have undergone transplantation. Of the 31 
patients removed from the active list, 25 are currently alive 
without listing for transplantation a d 5 have been relisted; 1 
of the 5 required hospitalization until transplantation; 1 un- 
derwent transplantation as an outpatient; 1,who was relisted 
because of increasing angina, has been on the list for >2 years; 
and 2 have just been relisted at 13 and 30 months, respectively, 
after removal from the list. Death from respiratory failure 
Figure 1. Flowchart depicting the outcome of
ambulatory transplant candidates with initial 
peak oxygen consumption (pkVO:) <14 ml/kg 
per rain. The patient who died of respiratory 
failure at 25 months because ofrecurrent pneu- 
mothoraces is described in Results. CHF = con- 
gestive heart failure death. 
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Figure 2. Actuarial survival for 31 patients aken offthe active waiting 
list for heart transplantation. The top line depicts 100% overall 
survival, with two patients censored from follow-up at the time of 
transplantation (tx). The middle line represents survival without (w/o) 
transplantation, with those two patients reaching an end point at the 
time of transplantation. The bottom line represents survival without 
relisting for transplantation, with relisting (four patients by 2 years) 
considered an end point. Not reflected in this 2-year graph are one 
patient who died of pulmonary disease at 25 months and one patient 
who was relisted at 30 months. Prob = probability of. 
occurred at 25 months in one patient who developed recurrent 
pneumothoraces, then severe restriction after sclerosing ther- 
apy, but did not develop any signs of recurrent congestion 
before death. The 28 outpatients without ransplantation are 
currently 21 + 10 months from the second exercise test. Even 
if the two patients who underwent ransplantation were 
counted as having died instead of as having undergone trans- 
plantation, the actuarial survival rate for candidates removed 
from the active list according to the preceding criteria was 97% 
at 1 year and 92% at 2 years (Fig. 2). The actuarial survival rate 
at 2 years without relisting for transplantation was 85%. 
Discuss ion  
This study demonstrates that peak oxygen uptake fre- 
quently improves while ambulatory candidates await heart 
transplantation. Most patients who demonstrate major im- 
provement also meet criteria for clinical stability, particularly if
baseline heart rate has decreased and peak oxygen pulse has 
increased. A strategy of candidate reevaluation that included 
repeat exercise testing identified apatient group with a short- 
term survival rate equivalent to that of patients after heart 
transplantation, despite initial peak oxygen uptake <14 ml/kg 
per min (average 11 ml/kg per min). 
Improvement in exercise capacity. Multiple interventions 
have been shown to improve exercise capacity in patients with 
heart failure. The majority of the improvement has been 
reported to occur during long-term therapy (13). Prolonged 
improvement of nutritive flow may be required to allow 
recovery of impaired skeletal muscle metabolism (14-16). 
Nitrate therapy, the hydralazine-nitrate combination and 
angiotensin-converting e zyme inhibitors have all been shown 
to improve long-term exercise capacity in patients with heart 
failure (6,7). The effect of amiodarone on exercise capacity has 
not been assessed in these patients. In addition, formal exer- 
cise training can improve peak oxygen consumption, with a 
20% increase described by Coats et al. (8) in patients with less 
severe heart failure. Although the patients in the current study 
did not undergo formal exercise programs, they were encour- 
aged to begin a progressive program of regular walking, which 
had frequently been specifically proscribed before referral. 
The patients in this study who showed improved exercise 
capacity had an average increase of 5 ml/kg per rain in peak 
oxygen uptake. Although multiple baseline tests could not be 
performed in this group, the improvement most likely reflects 
improved aerobic capacity, as there was >2 ml/kg per rain 
improvement also in the anaerobic threshold, which is less 
influenced than peak oxygen consumption by patient familiar- 
ity and effort. Lack of increase in the peak respiratory quotient 
on repeat testing makes it unlikely that patients were exercising 
to greater perceived intensity during the second test. 
The increased functional reserve in patients with major 
improvement i  both exercise and clinical status was associated 
with increased heart rate reserve during exercise, primarily due 
to a decreased heart rate at rest. The decreased heart rate may 
reflect increased vagal tone and decreased sympathetic one at 
rest, which has been demonstrated after formal exercise train- 
ing (8). The improved peak oxygen uptake was a product of 
both increased heart rate reserve and increased peak oxygen 
pulse, which reflects stroke volume and peripheral muscle 
utilization of oxygen. The increased peak systolic blood pres- 
sure may indicate a higher peak cardiac output or more 
efficient vasoconstriction f nonexercising vascular beds. In the 
seven patients who did not achieve clinical stability despite an 
improved peak oxygen uptake, peak heart rate increased 
without increased peak oxygen pulse or decrease in heart rate 
at rest. 
Prediction of improvement. The baseline clinical and hemo- 
dynamic profile of patients evaluated id not reveal any criteria 
for initial identification of those patients who had subsequent 
improvement. On initial exercise testing, peak work load and 
anaerobic threshold were higher in patients with later improve- 
ment, although there was considerable overlap. The initial peak 
heart rate and exercise heart rate reserve were higher in the group 
with subsequently improved exercise tolerance, but only in those 
who also had sufficient accompanying clinical stabilization to 
leave the waiting fist. The initial parasympathetic/sympathetic 
balance may have been less abnormal in this group. Hemody- 
namic data at the time of referral did not predict outcome, as 
previously shown (17) for such severely compromised patients, 
whose initial filling pressure and cardiac output may reflect 
primarily the intensity of prior treatment. Patients with and 
without coronary artery disease as their primary diagnosis dem- 
onstrated a similar chance of improvement. Previous history of 
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heavy alcohol consumption, which could cause reversible myocar- 
dial depression, was not commonly documented. 
Exercise capacity and eligibility for heart transplantation. 
The goal of the selection process is identification of those who 
will derive the greatest benefit from transplantation, i  terms 
of both quality of life and survival (9). Classical indications of 
"severe" or "end-stage" heart failure do not define the differ- 
ence between the candidate who can achieve clinical stability 
despite a low ejection fraction and the candidate who is 
plagued by persistent congestive symptoms despite optimal 
therapy. Measurement of oxygen uptake and estimated anaer- 
obic threshold allow more precise quantification of functional 
impairment in patients with heart failure (18), whose varying 
degrees of effort and tolerance for anaerobic metabolism limit 
the value of measuring peak work load or duration. Measure- 
ment of peak oxygen uptake allows comparison of functional 
capacity in a patient with heart failure with that achieved by the 
average heart transplant recipient, both of which can be 
improved with training (8,19). The patients in this study with 
improved exercise capacity had an average peak uptake of 
16 ml/kg per min on their repeat est, which is comparable to 
that achieved on the same testing protocol in the same 
institution 1 year after heart ransplantation (3)although lower 
than that in some other studies (19). 
Mancini et al. (5) showed that measurement of peak oxygen 
uptake provides information about survival as well as func- 
tional capacity. Transplant candidates with a peak oxygen 
uptake <14 ml/kg per rain had a 32% survival rate at 2 years 
without ransplantation compared to the 84% rate of those 
with higher oxygen uptake, a result hat has introduced a new 
objectivity into candidate selection. It should be noted that 
exercise in the current study was performed with a bicycle, on 
which normal subjects achieve a peak oxygen uptake 5% to 
10% lower than that achieved on a treadmill, which uses more 
muscle groups but may be less easy to standardize in compro- 
mised patients (20). 
Because peak oxygen consumption can improve with med- 
ical therapy and regular exercise itself, the value of the test for 
assessing both functional capacity and survival may increase 
when it is repeated after enhanced medical therapy and 
activity. The capacity to improve oxygen consumption may 
itself be a favorable prognostic sign, indicative of a permissive 
milieu of improved perfusion and activity reflecting a return 
toward more normal circulatory integration. This may be 
particularly true in the presence of a reduction i  heart rate at 
rest, consistent with increased parasympathetic tone, which has 
been associated with more favorable prognosis (21). 
Reevaluation of cardiac transplant candidates. There are 
currently >2,800 candidates awaiting heart ransplantation in 
the United States with >300 added each month. Thus, some 
6,400 patients will be on the list for some part of this year, 
during which -2,100 donor hearts will become available (1). 
The highest interval risk for these patients is during the first 
few months after evaluation. Candidates surviving this period 
may show improvement, as a result of both more intensive 
medical therapy and resolution of unrecognized xacerbating 
factors. The prolonged waiting times are actually selecting a 
group of patients with better survival rates than those of the 
group initially listed (2). After the ardors of selection and the 
ceremony of awarding the beeper, it may be difficult o convince 
a patient and his referring physician that his very survival may be 
an indication for removal from the list. Candidates who have 
responded well to medical therapy frequently ask, "Do I still need 
a transplant?", but they and their physicians fear loss of candi- 
dacy. Identification of a candidate who can defer or avoid 
transplantation thus requires definitive criteria. 
Among the 107 potential candidates with initial peak 
oxygen uptake <14 ml/kg per min, the 24 patients who did not 
undergo repeat testing because of severe angina, clinical 
deterioration rdeath were clearly candidates who could have 
benefited from transplantation. Some of the 15 outpatients 
who underwent elective transplantation before undergoing a 
second test may have demonstrated sufficient improvement to
postpone transplantation, but this cannot be known. For the 
29% of all the ambulatory patients listed with low peak oxygen 
uptake who were judged to have sufficient improvement to
leave the active list, the survival of 85% without relisting at an 
average of 21 months compares well with the 2-year posttrans- 
plant survival rate of 75% in the international registry (22). 
The longer-term prognosis for patients with severe heart 
failure remains very limited. Even in patients with milder heart 
failure in the VHEFT study and symptomatic arm of the 
SOLVD trial, the 4-year survival rate was 50%-60% (23,24). 
The 5-year survival rate after heart ransplantation is >70% in 
major centers. The life span of a transplanted heart is limited, 
however, by accelerated coronary vasculopathy, which affects 
>50% of recipients by 5 years and is a major cause of late 
mortality (25). The total life expectancy is maximized by 
waiting as long as possible before transplantation, as long as 
functional capacity and 1-year prognosis remain similar to 
those expected from transplantation. The quality of life is 
clearly maximized also by reducing time spent waiting for 
transplantation, a state characterized by unique anxiety and 
family stresses. Rather than looking at 5-year survival from the 
outset, it may be more appropriate oconsider only 1 year at a 
time when timing transplantation. 
The major obstacle to rational listing and reevaluation of
potential transplant candidates i  a lack of consensus among 
programs. The long waiting times stimulate arlier listing of 
patients to "build up time on the list," whereas newly listed 
outpatients with greater immediate need may die for lack of a 
heart. Like disarmament, a policy leading to more effective use 
of limited resources requires simultaneous cooperation to a 
greater degree than has been evident among transplant centers 
(26). 
Limitations, As the routine study of these compromised 
patients did not include repeat baseline exercise, improved 
oxygen uptake may have resulted partly from familiarity with 
the testing apparatus. The use of a 6 rain warm up period, lack 
of improvement in many patients and concordance of in- 
creased anaerobic threshold suggest hat improved oxygen 
uptake reflected true improvement in aerobic apacity. Other 
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indexes of improvement, such as precise jection fraction, may 
also be helpful (27). 
The results of this study can be applied only to ambulatory 
patients able to undergo exercise testing. Inability to perform 
bicycle exercise may indicate greater isk. Low peak oxygen 
consumption must be considered in relation to predicted 
values and individual patient trends as only one of several 
indications for transplantation, which include refractory ar- 
rhythmias or severe uncorrectable myocardial ischemia (26). 
Implications. This study represents a first step toward the 
establishment of guidelines for reevaluation ofheart ransplant 
candidates. The lack of information at listing that predicts later 
improvement s rengthens the concept hat transplant candi- 
dacy is a dynamic state. As waiting lists lengthen further, 
systematic reevaluation may increase overall survival, both by 
lengthening the time of quality life before transplantation a d 
by distributing the donor hearts expeditiously to those candi- 
dates who are least likely to survive without hem. 
We gratefully acknowledge the expert statistical contribution ofAlex Kartashov, 
PhD, Brigham and Women's Hospital, Boston, Massachusetts. 
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